Addison Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

Addison Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,600	Closed	-$6.46K	–	889
2025 Q1	$6.46K	Hold	1,600	–	–	﹤0.01%	643
2024 Q4	$5.12K	Buy	+1,600	New	+$5.42K	﹤0.01%	668

Addison Advisors's CKPT Position: Q2 2025 in Review

Addison Advisors sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 1,600 shares — an estimated $6.46K sold.

Addison Advisors first reported a position in CKPT in Q4 2024 and held it in 2 quarters. The position peaked at $6.46K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Addison Advisors reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Addison Advisors sold 1,600 Checkpoint Therapeutics shares in Q2 2025, an estimated $6.46K.
Addison Advisors first reported a position in Checkpoint Therapeutics in Q4 2024 and held it in 2 quarters.
Addison Advisors's Checkpoint Therapeutics position peaked at $6.46K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Addison Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.